Literature DB >> 17661674

Biomarker discovery in infectious diseases using SELDI.

Andrea Hodgetts1, Michael Levin, J Simon Kroll, Paul R Langford.   

Abstract

Surface enhanced laser desorption ionization-time of flight is a mass spectrometric-based method that requires a minimal amount of sample for analysis and can be used for high-throughput screening. It has been used to discover serum or tissue protein signatures and biomarkers for infectious diseases in the fields of virology (hepatitis B and C viruses, severe acute respiratory syndrome, HIV-1, human T-cell leukemia virus-1 and BK virus), parasitology (trypanosomiasis) and bacteriology (intra-amniotic inflammation, tuberculosis and bacterial endocarditis). The protein signatures, or biomarkers, can be used to diagnose infection, predict disease states and to inform on disease processes. Careful attention to experimental design, sample handling and storage, and the use of appropriate internal controls is crucial to success.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17661674     DOI: 10.2217/17460913.2.1.35

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  21 in total

1.  A genetic programming approach for Burkholderia pseudomallei diagnostic pattern discovery.

Authors:  Zheng Rong Yang; Ganjana Lertmemongkolchai; Gladys Tan; Philip L Felgner; Richard Titball
Journal:  Bioinformatics       Date:  2009-06-26       Impact factor: 6.937

Review 2.  Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.

Authors:  Muriel De Bock; Dominique de Seny; Marie-Alice Meuwis; Jean-Paul Chapelle; Edouard Louis; Michel Malaise; Marie-Paule Merville; Marianne Fillet
Journal:  J Biomed Biotechnol       Date:  2009-12-06

3.  Novel Sample Preparation for Mass Spectral Analysis of Complex Biological Samples.

Authors:  Eric A Porsch; Cecelia A Shertz; Michael D Boyle
Journal:  Curr Proteomics       Date:  2010-07       Impact factor: 0.837

4.  Discovery and characterization of potential prognostic biomarkers for dengue hemorrhagic fever.

Authors:  B Katherine Poole-Smith; Alexa Gilbert; Andrea L Gonzalez; Manuela Beltran; Kay M Tomashek; Brian J Ward; Elizabeth A Hunsperger; Momar Ndao
Journal:  Am J Trop Med Hyg       Date:  2014-10-27       Impact factor: 2.345

5.  Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis.

Authors:  C Trocmé; H Marotte; A Baillet; B Pallot-Prades; J Garin; L Grange; P Miossec; J Tebib; F Berger; M J Nissen; R Juvin; F Morel; P Gaudin
Journal:  Ann Rheum Dis       Date:  2008-07-29       Impact factor: 19.103

Review 6.  Searching for the elusive typhoid diagnostic.

Authors:  Stephen Baker; Michael Favorov; Gordon Dougan
Journal:  BMC Infect Dis       Date:  2010-03-05       Impact factor: 3.090

7.  Separation of peptides with polyionic nanosponges for MALDI-MS analysis.

Authors:  Ven Ney Wong; Ganga Fernando; Audrey R Wagner; Jianming Zhang; Gary R Kinsel; Stefan Zauscher; Daniel J Dyer
Journal:  Langmuir       Date:  2009-02-03       Impact factor: 3.882

8.  Identification of serum proteomic biomarkers for early porcine reproductive and respiratory syndrome (PRRS) infection.

Authors:  Sem Genini; Thomas Paternoster; Alessia Costa; Sara Botti; Mario Vittorio Luini; Andrea Caprera; Elisabetta Giuffra
Journal:  Proteome Sci       Date:  2012-08-08       Impact factor: 2.480

Review 9.  The proteomics big challenge for biomarkers and new drug-targets discovery.

Authors:  Rocco Savino; Sergio Paduano; Mariaimmacolata Preianò; Rosa Terracciano
Journal:  Int J Mol Sci       Date:  2012-10-29       Impact factor: 5.923

10.  Severe childhood malaria syndromes defined by plasma proteome profiles.

Authors:  Florence Burté; Biobele J Brown; Adebola E Orimadegun; Wasiu A Ajetunmobi; Francesca Battaglia; Barry K Ely; Nathaniel K Afolabi; Dimitrios Athanasakis; Francis Akinkunmi; Olayinka Kowobari; Samuel Omokhodion; Kikelomo Osinusi; Felix O Akinbami; Wuraola A Shokunbi; Olugbemiro Sodeinde; Delmiro Fernandez-Reyes
Journal:  PLoS One       Date:  2012-12-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.